Table of Contents
Volume 3 | Issue 4
Publication Date: May 2002- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
234 |
Drug Discovery and Targets for Therapy Chandra P. Belani |
|
Researches in Brief | ||
237-239 |
LY900003 (Affinitac™), an Antisense Inhibitor of Protein Kinase C–α, in Non–Small-Cell Lung Cancer Kavita Maung, Chandra P. Belani, Vinay K. Jain |
|
240-242 |
Pemetrexed (Alimta®): A Novel Antifolate in the Treatment of Malignant Pleural Mesothelioma Kavita Maung, Chandra P. Belani, Vinay K. Jain |
|
Comprehensive Reviews | ||
243-248 |
Results of Recent Japanese Clinical Trials in Lung Cancer Yuichiro Ohe, Nagahiro Saijo |
|
249-253 |
The Value of Platinum Compounds in Non–Small-Cell Lung Cancer Nasser H. Hanna, Lawrence H. Einhorn |
|
Original Contributions | ||
254-258 |
Temozolomide in Non–Small-Cell Lung Cancer: Preliminary Results of a Phase II Trial in Previously Treated Patients Christian S. Adonizio, James S. Babb, Christine Maiale, Chao Huang, Judy Donahue, Michael M. Millenson, Martha Hosford, Robert Somer, Joseph Treat, Eric Sherman, Corey J. Langer |
|
259-264 |
Update on Results of Multifield Conformal Radiation Therapy of Non–Small-Cell Lung Cancer Using Multileaf Collimated Beams Ajay Bhatnagar, John C. Flickinger, Sanjeev Bahri, Melvin Deutsch, Chandra Belani, James D. Luketich, Joel S. Greenberger |
|
265-270 |
Phase I Study of Dose-Dense Alternating Doublets in Advanced Non–Small-Cell Lung Cancer Everett E. Vokes, Chaiyut Charoentum, Gary S. Gordon, Charles M. Rudin, Stuart A. Krauss, Philip C. Hoffman, Ann M. Mauer, Susie Lee, Sylvia Watson |
|
Translational Medicine | ||
271-277 |
The Future of Cyclooxygenase-2 Inhibitors and Other Inhibitors of the Eicosanoid Signal Pathway in the Prevention and Therapy of Lung Cancer Paul A. Bunn, Jr., Robert L. Keith |
|
Commentary | ||
278 |
Jettisoning the COXswain: Inhibitors of Eicosanoids and Lung Cancer Adi F. Gazdar |
|